Stock With Great Potential

From Wealthy Millionaire | Ad

Analyst says this stock could make quick strides with its unbelievable assets.

Learn more

ADMP Insider Trading (Adamis Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $20,526.63

Adamis Pharmaceuticals Insider Trading History Chart

Adamis Pharmaceuticals Share Price & Price History

^$0.43

▼ -0.0325 (-7.07%)

As of 05/17/2022 02:27 PM ET

Days: 30 | 90 | 365

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Adamis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2022	David C Benedicto	CFO	Sell	3,603	$0.61	$2,197.83
3/18/2022	David J Marguglio	SVP	Sell	11,859	$0.60	$7,115.40
3/18/2022	Dennis J Phd Carlo	CEO	Sell	10,490	$0.60	$6,294.00
3/18/2022	Ronald B Moss	Insider	Sell	8,199	$0.60	$4,919.40
11/20/2020	David J Marguglio	SVP	Sell	35,000	$0.40	$14,000.00	287,264
9/29/2020	Robert O Hopkins	CFO	Sell	20,000	$0.80	$16,000.00	274,781
8/18/2020	David J. Marguglio	SVP	Sell	8,749	$0.87	$7,611.63
8/18/2020	Dennis J. Phd Carlo	CEO	Sell	10,929	$0.87	$9,508.23
8/18/2020	Karen K. Daniels	VP	Sell	5,480	$0.87	$4,767.60
8/18/2020	Robert O. Hopkins	CFO	Sell	7,418	$0.87	$6,453.66
3/18/2020	Dennis J Phd Carlo	CEO	Sell	10,645	$0.34	$3,619.30	320,089
3/18/2020	Karen K Daniels	VP	Sell	6,461	$0.34	$2,196.74	150,999
3/18/2020	Robert O Hopkins	CFO	Sell	8,749	$0.34	$2,974.66	308,731
3/18/2020	Ronald B Moss	Insider	Sell	10,337	$0.34	$3,514.58	242,858
2/24/2020	David J Marguglio	SVP	Sell	9,948	$0.60	$5,968.80	335,359
2/24/2020	Dennis J Phd Carlo	CEO	Sell	12,436	$0.60	$7,461.60	330,734
2/24/2020	Karen K Daniels	VP	Sell	6,229	$0.60	$3,737.40	157,460
2/24/2020	Robert O Hopkins	CFO	Sell	8,420	$0.60	$5,052.00	317,480
11/18/2019	David J Marguglio	SVP	Sell	8,283	$0.87	$7,206.21	365,307
11/18/2019	Dennis J Phd Carlo	CEO	Sell	10,760	$0.84	$9,038.40	343,170
11/18/2019	Karen K Daniels	VP	Sell	5,421	$0.83	$4,499.43	163,689
11/18/2019	Robert O Hopkins	CFO	Sell	7,347	$0.83	$6,098.01	325,900
11/18/2019	Ronald B Moss	Insider	Sell	8,448	$0.85	$7,180.80	259,424
8/19/2019	David J Marguglio	SVP	Sell	8,109	$1.10	$8,919.90	373,590
8/19/2019	Dennis J Phd Carlo	CEO	Sell	10,477	$1.06	$11,105.62	353,930
8/19/2019	Karen K Daniels	VP	Sell	5,243	$1.06	$5,557.58	169,110
8/19/2019	Robert O Hopkins	CFO	Sell	7,101	$1.06	$7,527.06	333,247
8/19/2019	Ronald B Moss	Insider	Sell	8,383	$1.06	$8,885.98	267,872
5/24/2019	Robert B Rothermel	Director	Buy	6,500	$1.58	$10,270.00	133,500
5/20/2019	David J Marguglio	SVP	Sell	8,735	$1.77	$15,460.95	381,699
5/20/2019	Dennis J Phd Carlo	CEO	Sell	11,184	$1.73	$19,348.32	364,407
5/20/2019	Karen K Daniels	VP	Sell	5,591	$1.73	$9,672.43	174,353
5/20/2019	Robert O Hopkins	CFO	Sell	7,559	$1.73	$13,077.07	340,348
5/20/2019	Ronald B Moss	Insider	Sell	8,741	$1.77	$15,471.57	276,255

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

SEC Filings (Institutional Ownership Changes) for Adamis Pharmaceuticals (NASDAQ:ADMP)

9.52% of Adamis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adamis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2022	State Street Corp	475,373	$0.27M	0.0%	+13.1%	0.317%
5/16/2022	UBS Group AG	66,653	$39K	0.0%	-54.1%	0.045%
5/13/2022	Vanguard Group Inc.	6,480,688	$3.70M	0.0%	-0.6%	4.328%
5/11/2022	JPMorgan Chase & Co.	84,775	$48K	0.0%	-61.2%	0.057%
5/2/2022	Verdence Capital Advisors LLC	58,382	$33K	0.0%	-59.3%	0.039%
4/25/2022	Capital CS Group LLC	70,513	$40K	0.0%	N/A	0.047%
2/17/2022	Virtu Financial LLC	224,561	$0.14M	0.0%	+9.6%	0.151%
2/15/2022	Millennium Management LLC	138,666	$84K	0.0%	-75.1%	0.093%
2/11/2022	Geode Capital Management LLC	1,293,316	$0.78M	0.0%	-3.0%	0.869%
2/10/2022	JPMorgan Chase & Co.	218,573	$0.13M	0.0%	+735.2%	0.147%
1/24/2022	Avantax Advisory Services Inc.	54,000	$33K	0.0%	+68.8%	0.036%
11/16/2021	Millennium Management LLC	557,157	$0.54M	0.0%	+3,449.4%	0.374%
11/15/2021	Atom Investors LP	56,492	$55K	0.0%	N/A	0.038%
11/12/2021	Geode Capital Management LLC	1,333,913	$1.29M	0.0%	+3.7%	0.896%
8/17/2021	Balyasny Asset Management LLC	1,622,510	$1.79M	0.0%	N/A	1.090%
8/16/2021	Squarepoint Ops LLC	114,188	$0.13M	0.0%	+785.6%	0.077%
8/16/2021	Greenlight Capital Inc.	1,000,000	$1.10M	0.1%	N/A	0.672%
8/16/2021	State Street Corp	420,205	$0.46M	0.0%	+835.9%	0.282%
8/16/2021	Goldman Sachs Group Inc.	241,991	$0.27M	0.0%	N/A	0.163%
8/13/2021	Natixis	38,600	$42K	0.0%	N/A	0.026%
8/13/2021	Geode Capital Management LLC	1,286,139	$1.41M	0.0%	+19.4%	0.864%
8/13/2021	Vanguard Group Inc.	6,313,841	$6.95M	0.0%	+10.2%	4.241%
8/12/2021	JPMorgan Chase & Co.	42,900	$47K	0.0%	+261.6%	0.029%
8/11/2021	Bank of New York Mellon Corp	84,002	$92K	0.0%	N/A	0.056%
8/11/2021	BlackRock Inc.	2,742,498	$3.02M	0.0%	+45.2%	1.842%
8/10/2021	Principal Financial Group Inc.	32,384	$36K	0.0%	N/A	0.022%
8/6/2021	Verdence Capital Advisors LLC	143,382	$0.16M	0.0%	+145.6%	0.096%
5/19/2021	Virtu Financial LLC	346,296	$0.33M	0.0%	N/A	0.233%
5/18/2021	Millennium Management LLC	414,540	$0.39M	0.0%	N/A	0.278%
5/17/2021	Edmond DE Rothschild Holding S.A.	100,000	$94K	0.0%	N/A	0.067%
5/14/2021	Stifel Financial Corp	40,000	$38K	0.0%	N/A	0.027%
5/13/2021	Barclays PLC	31,654	$30K	0.0%	N/A	0.021%
5/13/2021	Renaissance Technologies LLC	822,655	$0.77M	0.0%	N/A	0.553%
5/12/2021	Northern Trust Corp	258,851	$0.24M	0.0%	+50.5%	0.174%
5/12/2021	Geode Capital Management LLC	1,076,975	$1.01M	0.0%	+92.9%	0.723%
5/12/2021	UBS Group AG	50,000	$47K	0.0%	-27.3%	0.034%
5/7/2021	BlackRock Inc.	1,888,314	$1.78M	0.0%	+41.6%	1.268%
3/26/2021	Susquehanna International Group LLP	271,626	$0.13M	0.0%	-9.7%	0.202%
2/12/2021	Verdence Capital Advisors LLC	58,382	$28K	0.0%	-33.9%	0.065%
2/4/2021	GSA Capital Partners LLP	516,203	$0.25M	0.0%	+825.9%	0.573%
12/11/2020	Virtu Financial LLC	39,683	$31K	0.0%	N/A	0.044%
11/9/2020	Verdence Capital Advisors LLC	88,382	$69K	0.0%	N/A	0.098%
11/6/2020	GSA Capital Partners LLP	55,752	$44K	0.0%	N/A	0.062%
11/2/2020	Level Four Advisory Services LLC	32,000	$25K	0.0%	-40.2%	0.036%
10/29/2020	Cambridge Investment Research Advisors Inc.	46,849	$37K	0.0%	N/A	0.052%
7/31/2020	UBS Group AG	61,575	$33K	0.0%	+426.3%	0.083%
5/15/2020	Sabby Management LLC	88,210	$32K	0.0%	N/A	0.121%
2/20/2020	Geode Capital Management LLC	629,742	$0.44M	0.0%	+86.8%	1.022%
10/17/2019	Wedbush Securities Inc.	86,600	$61K	0.0%	+94.2%	0.141%
8/16/2019	First Manhattan Co.	1,391,733	$1.81M	0.0%	-58.5%	2.265%
8/14/2019	Morgan Stanley	757,124	$0.98M	0.0%	+189.7%	1.589%
8/14/2019	Vanguard Group Inc.	1,791,266	$2.33M	0.0%	+4.5%	3.760%
8/14/2019	A.R.T. Advisors LLC	61,711	$80K	0.0%	+143.8%	0.130%
8/13/2019	BlackRock Inc.	962,687	$1.25M	0.0%	+1.5%	2.021%
8/6/2019	GSA Capital Partners LLP	139,605	$0.18M	0.0%	N/A	0.293%
8/1/2019	Wedbush Securities Inc.	44,600	$58K	0.0%	+139.8%	0.094%
6/30/2019	Leisure Capital Management	22,311	$29K	0.0%	-80.7%	0.047%
5/10/2019	DekaBank Deutsche Girozentrale	1,200,000	$3.36M	0.0%	N/A	2.537%
5/8/2019	National Asset Management Inc.	29,920	$64K	0.0%	+28.9%	0.063%
5/8/2019	Leisure Capital Management	115,724	$0.24M	0.2%	+4.5%	0.245%
4/17/2019	Wedbush Securities Inc.	18,600	$39K	0.0%	N/A	0.039%
4/12/2019	Virtu Financial LLC	20,588	$43K	0.0%	N/A	0.044%
4/12/2019	First Manhattan Co.	3,352,333	$7.07M	0.0%	-2.0%	7.089%
2/15/2019	Jane Street Group LLC	13,740	$31K	0.0%	N/A	0.029%
2/14/2019	Barclays PLC	48,700	$0.11M	0.0%	N/A	0.103%
2/13/2019	Geode Capital Management LLC	301,330	$0.68M	0.0%	+18.9%	0.637%
2/12/2019	Northern Trust Corp	166,170	$0.37M	0.0%	-2.0%	0.351%
2/11/2019	Raymond James Financial Services Advisors Inc.	14,317	$32K	0.0%	-28.9%	0.030%
2/11/2019	Raymond James & Associates	49,596	$0.11M	0.0%	+56.5%	0.105%
2/8/2019	BlackRock Inc.	963,864	$2.17M	0.0%	+8.4%	2.038%
2/7/2019	LPL Financial LLC	15,490	$35K	0.0%	-31.4%	0.033%
2/5/2019	Cambridge Investment Research Advisors Inc.	16,001	$36K	0.0%	N/A	0.034%
1/29/2019	Oppenheimer & Co. Inc.	17,000	$38K	0.0%	N/A	0.036%
12/13/2018	Vanguard Group Inc	1,637,513	$5.73M	0.0%	+27.1%	3.463%
11/23/2018	Vanguard Group Inc.	1,637,513	$5.73M	0.0%	+27.1%	3.463%
11/14/2018	Perceptive Advisors LLC	137,500	$0.48M	0.0%	N/A	0.291%
11/9/2018	DekaBank Deutsche Girozentrale	1,200,000	$3.36M	0.0%	+71.4%	2.538%
11/9/2018	BlackRock Inc.	889,440	$3.11M	0.0%	+203.2%	1.881%
11/9/2018	Leisure Capital Management	120,940	$0.42M	0.3%	-23.1%	0.256%
10/15/2018	First Manhattan Co.	3,419,269	$11.97M	0.1%	N/A	7.230%
10/3/2018	Acropolis Investment Management LLC	30,000	$0.11M	0.0%	N/A	0.063%
8/9/2018	BlackRock Inc.	293,328	$0.94M	0.0%	+7.7%	0.878%
5/11/2018	Dimensional Fund Advisors LP	69,790	$0.24M	0.0%	N/A	0.209%
5/9/2018	Northern Trust Corp	139,536	$0.49M	0.0%	+50.7%	0.418%
2/10/2018	B. Riley Financial Inc.	232,228	$1.02M	0.3%	N/A	0.696%
2/9/2018	Virtu Financial LLC	100,363	$0.44M	0.0%	N/A	0.301%
2/8/2018	Wells Fargo & Company MN	28,182	$0.12M	0.0%	+1,050.3%	0.084%
11/8/2017	EAM Investors LLC	371,732	$1.94M	0.3%	+58.3%	1.186%
11/8/2017	Granite Investment Partners LLC	87,611	$0.46M	0.0%	N/A	0.279%
11/6/2017	Bank of New York Mellon Corp	27,464	$0.14M	0.0%	+131.0%	0.088%
11/6/2017	Advisor Group Inc.	56,001	$0.29M	0.0%	+149.9%	0.179%
8/15/2017	Stonebridge Capital Advisors LLC	27,500	$0.14M	0.0%	+22.2%	0.100%
8/14/2017	DAFNA Capital Management LLC	24,401	$0.13M	0.1%	-18.7%	0.089%
8/14/2017	First Allied Advisory Services Inc.	22,000	$0.11M	0.0%	N/A	0.080%
8/11/2017	Virtu KCG Holdings LLC	38,474	$0.20M	0.0%	+103.2%	0.140%
8/11/2017	EAM Investors LLC	234,762	$1.22M	0.2%	N/A	0.852%
8/11/2017	Vanguard Group Inc.	942,940	$4.90M	0.0%	+22.2%	3.421%
8/10/2017	Bard Associates Inc.	153,050	$0.80M	0.4%	No Change	0.555%
8/10/2017	Wells Fargo & Company MN	32,500	$0.17M	0.0%	N/A	0.118%
8/9/2017	Leisure Capital Management	145,909	$0.76M	0.7%	+7.2%	0.529%

Data available starting January 2016

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $0.43

$0.32

$0.43

50 Day Range

MA: $0.51

$0.34

$0.64

52 Week Range

Now: $0.43

$0.31

$1.48

Volume

13,419 shs

Average Volume

696,560 shs

Market Capitalization

$64.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Adamis Pharmaceuticals?: Adamis Pharmaceuticals' top insider investors include:
David J Marguglio (SVP)
Robert O Hopkins (CFO)
David C Benedicto (CFO)
David J Marguglio (SVP)
Dennis J Phd Carlo (CEO)
Karen K Daniels (VP)
Robert O Hopkins (CFO)
Ronald B Moss (Insider)
Learn More about top insider investors at Adamis Pharmaceuticals.
Who are the major institutional investors of Adamis Pharmaceuticals?: Adamis Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 4.33%
State Street Corp — 0.32%
JPMorgan Chase & Co. — 0.06%
Capital CS Group LLC — 0.05%
UBS Group AG — 0.04%
Verdence Capital Advisors LLC — 0.04%
Learn More about top institutional investors of Adamis Pharmaceuticals stock.
Which major investors are selling Adamis Pharmaceuticals stock?: Within the previous quarter, ADMP stock was sold by these institutional investors:
JPMorgan Chase & Co.
Verdence Capital Advisors LLC
UBS Group AG
Vanguard Group Inc.
During the last year, company insiders that have sold Adamis Pharmaceuticals company stock include:
David J Marguglio (SVP)
Robert O Hopkins (CFO)
David C Benedicto (CFO)
David J Marguglio (SVP)
Learn More investors selling Adamis Pharmaceuticals stock.
Which major investors are buying Adamis Pharmaceuticals stock?: In the previous quarter, ADMP stock was bought by institutional investors including:
Capital CS Group LLC
State Street Corp
Simplex Trading LLC
Group One Trading L.P.